Blood pressure (BP) reactivity to orthostatic tilt may be predictive of cardiovascular disease. However, the genetic and environmental influences on BP reactivity to tilt have not been well examined. Identifying different influences on BP at rest and BP during tilt is complicated by the intercorrelation among multiple measurements. In this study, we use principal components analysis (PCA) to reduce multivariate BP data into components that are orthogonal. The objective of this study is to characterize and examine the genetic architecture of BP at rest and during head-up tilt (HUT). Specifically, we estimate the heritability of individual BP measures and three principal components (PC) derived from multiple BP measurements during HUT. Additionally, we estimate covariate effects on these traits. The study sample consisted of 444 individuals, distributed across four large families. HUT consisted of 701 head-up table tilting while strapped to a tilt table. BP reactivity (DBP) was defined as BP during HUT minus BP while supine. Three PC extracted fromIntroduction Exaggerated blood pressure (BP) reactivity to physiological stressors may be predictive of coronary heart disease, 1-4 stroke 5 and hypertension. [6] [7] [8] However, not all studies have reached the same conclusion. 9, 10 One reason for these equivocal results is the fact that genetic factors are rarely accounted for in studies of BP reactivity. 11, 12 A few studies have shown evidence for genes influencing BP changes in response to orthostasis (i.e., postural change), [13] [14] [15] but one aspect of this research that has been largely ignored is the identification of unique or shared genetic influences on different BP measures at rest and during orthostasis. In other words, do the same genes regulate BP both at rest and during orthostasis? If different genes influence BP during the challenge state, then there is the potential to identify a set of genes unique from those that influence resting BP and that may predispose certain individuals to increased cardiovascular disease (CVD) risk.
Identifying different influences on BP at rest and BP during challenge is difficult because both sets of measurements are intercorrelated and are likely to at least partly share common genetic and environmental effects as well as physiological pathways. One approach to dealing with many inter correlated study variables is to use principal components analysis (PCA). 16 PCA is a data reduction method that can help identify latent factors or principal components (PC) that underlie multivariate BP data by simultaneously incorporating information from each BP measurement. This process also helps to reduce redundancy among BP data because the resulting components are orthogonal or independent from one another. By using PCA, we thus are able to use all of the information captured in our many BP measurements, yet simplify our examination of BP because the PCA leaves us with (1) a reduced number of BP measurements to be assessed, and (2) a new characterization of BP variation. The extracted PC may, in turn, describe underlying latent factors involved in BP response to postural change that are themselves under genetic control.
The purpose of this study is (1) to estimate the heritability of BP at rest and during orthostatic headup tilting (HUT), (2) to conduct PCA in order to extract PC characterizing BP measurements at rest and during HUT and (3) to estimate the heritability of each principal component.
Materials and methods

Study population
The Southwest Ohio Family Study is a genetic epidemiologic study of hypertension and CVD risks, and is comprised of five large multi-generational families (one predominantly African American and four predominantly European American) whose members reside in the greater Dayton, OH area. Briefly, each family in the Southwest Ohio Family Study was ascertained on a single male proband aged 35-58 years with essential hypertension (diastolic BP 495 mmHg). Family members of these five men were screened for participation in a study of genetic factors in hypertension and CVD risk, regardless of hypertensive status. Given the large family size and the small number of probands, adjustment for ascertainment was not performed. Data from these participants were initially collected in the late 1970s to early 1980s. 17 A follow-up study of this original cohort began in 2000. More details regarding the study population can be found in Choh et al. 18 and Siervogel et al. 17 Data collected during the early phase of the study (i.e., [1976] [1977] [1978] [1979] were analyzed for this paper. Informed consent was approved by the Institutional Review Board of Wright State University.
Only data from European American families were used in these analyses, as the distribution of BP values in African Americans is different from that of European Americans, both in the resting state 19 and during physiological stress. 3, 4, 6 A total of 444 participants (207 males, 237 females) between the ages of 7 and 72 years had at least one BP measurement at rest (sitting and supine) or during the tilt challenge (for up to 3 min). These individuals also had complete information for several potentially important covariates such as age, sex, body mass, smoking and use of hypertensive medication.
A subset of 330 individuals had complete BP data for every time point. These individuals provided the data for the PCA. The mean BP, age and body mass index (BMI) values of these 330 individuals did not significantly differ from the rest of the sample (i.e., those missing at least one BP measurement).
The rates of smoking, medication use and the sex composition among the subset of individuals also did not differ from the rest of the sample.
Measurements BP measurements were recorded using the Electronics for Medicine VR-12 photographic recorder (PPG Biomedical Systems, Pennsylvania, USA) and a NARCO programmed electric sphygmomanometer (Narco Biosystem, Texas, USA). Resting BP measurements were obtained from participants while seated and while supine. Systolic (SBP) and diastolic (DBP) blood pressures were obtained from the right arm of participants 10 min after sitting and 15 min after reclining. Participants were secured to a tilting table with straps placed across the abdomen. Tilting consisted of a 701 HUT. Single measurements of SBP and DBP were collected during the last 20 s of each minute for up to 3 min (HUT 1 , HUT 2 , HUT 3 ). BP reactivity was calculated by subtracting resting supine BP from BP during HUT at 1 min (DBP 1 ), 2 min (DBP 2 ) and 3 min (DBP 3 ).
Anthropometrics (height and weight) were taken following standard protocols. 20 BMI was calculated as weight (kg)/height (m 2 ). Individuals were considered current smokers if they were smokers at the time of the study visit, whereas past smokers and those who never smoked were considered to be nonsmokers. Individuals taking hypertensive medication in the year before their study visit were considered to be using hypertensive medication.
Statistical analysis
Individual BP measurements (i.e., resting BP, BP during HUT and BP reactivity) were examined in initial quantitative genetic analyses and used in the PCA (n ¼ 444). Principal component scores for interpretable components were also used as phenotypes in quantitative genetic analyses (n ¼ 330).
Principal components analysis PCA was conducted using BP measurements taken at rest and during HUT in order to characterize the underlying physiology of BP response to challenge and to consolidate the BP information into a smaller number of variables. Analyses were performed using SAS version 9.1 for Windows (SAS Institute Inc., Cary, North Carolina, USA).
For each individual, the first principal component (PC1) score is calculated as a linear combination given by:
where X 1 through X p are the original variables, and a 11 through a 1p are the loadings or eigenvectors, which represent the degree of the correlation between the original variables and PC1. 16, 21 In PCA, the variance of PC1 is maximized, and the sum of the squared loadings ( P a 2 1j ) is constrained to one. 16 The magnitude and direction of the loadings or eigenvectors are used to interpret the orthogonal components. Readers interested in the details of PCA are referred to the references listed above as well as Tabachnick and Fidell 22 and Stevens. 23 As we were interested in identifying underlying latent factors that characterize BP reactivity, the resulting PC were extracted regardless of their eigenvalue, as long as they were interpretable. Calculated principal component scores from each individual were then saved and used as variables in subsequent quantitative genetic analyses.
Quantitative genetic analysis
Maximum-likelihood variance decomposition methods were used to estimate the heritability (h 2 ) of each BP measure taken at rest and during HUT, as well as the BP reactivity to HUT. In addition, the heritability of each component extracted from the PCA was also estimated. Procedures used are implemented in the software package SOLAR (v. 2.12). 24 For individual, continuously distributed, quantitative traits, the covariance matrix for a pedigree is given by:
where F is the n Â n matrix of kinship coefficients that structures s 2 G , the variance due to additive genetic effects, and I is an identity matrix of order n that serves as the structuring matrix for s 2 E , the variance due to unmeasured, non-genetic factors. Heritability, defined as the proportion of the phenotypic variance attributable to additive genetic effects, is estimated as:
where s 2 G is the additive genetic variance and s 2 P is the phenotypic variance.
The trait mean and mean effects of age, sex, age 2 , age Â sex and age 2 Â sex were simultaneously estimated along with BMI, cigarette smoking and hypertensive medication use. Significance of h 2 was determined using the likelihood ratio test 25 by comparing the log likelihood of the general model to that of the nested model in which h 2 was fixed to zero. Table 1 shows the descriptive statistics of the study data. The mean BP at rest for SBP and DBP were within normal range as defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. 26 The crude prevalence of individuals with hypertension, based on a seated BPX 140/90 mmHg or hypertensive medication use, is 16.9%. Of the three different time periods, SBP reactivity at 2 min (DSBP 2 ) and DBP reactivity at 1 min (DDBP 1 ) had the largest variances. The mean 29 depending on the definition used.
Results
Study sample characteristics
The four families included in this study consisted of from 35 to 163 individuals with a mean family size of 111. Table 2 shows the number and type of relative pairings contained in the study sample of 444 individuals. In all, there were a total of 17 624 relative pairings of varying degrees of relationship to one another that contributed familial information to the genetic analyses.
Heritability estimates of individual BP measurements
Heritability estimates for BP at rest, BP during HUT and BP reactivity to HUT are shown in Table 3 Combined covariate effects accounted for 27.0-37.1% of the variation in SBP and DBP at rest, and they accounted for 23.6-32.6% of the variation in SBP and DBP during HUT. Among BP reactivity measures, covariates accounted for substantially less variation, (3.5-8.9%). Specific covariate effects for individual BP measures were somewhat inconsistent. Age had an influence on all of the DBP measurements at rest, during HUT and BP reactivity, but not on most of the corresponding SBP measurements. Males tended to have higher BP than females at rest and during HUT. Sex was not significant for most of the BP reactivity measurements. Individuals with higher BMI had higher BP at rest and during HUT, but BMI did not have an effect on four of the six BP reactivity measurements. Individuals taking hypertensive medication tended to have higher BP measurements for five out of the 10 BP measurements at rest and during HUT. Hypertensive medication use did not appear to influence BP reactivity. Smoking was only significant for seated DBP and the relationship was negative.
Principal components analysis
Three interpretable components that together accounted for 87% of the total variance were extracted from the 10 BP variables at rest and during HUT. Figure 1 shows that PC1, which accounted for 70.3% of the total variance in BP measures, had loadings that were approximately equal and positive for all 10 original BP measurements. PC1 thus can be interpreted as 'general BP', where higher positive PC1 scores reflect higher 'general BP'. PC2, which accounted for 10.2% of the total variance in BP measures, loaded positively and approximately equally for all DBP measurements, while loading negatively and approximately equally for all SBP measurements. The contrast between the DBP and SBP in PC2 thus may be interpreted as 'pulse pressure', where lower (i.e., larger negative) PC2 scores reflect higher 'pulse pressure'. When we examined 'pulse pressure' (PC2) and conventionally calculated measures of PP, we found them to be highly correlated; correlations between PC2 and measures of seated and supine PP ranged from À0.689 to À0.720.
PC3, which accounted for 6.4% of the total variance, was characterized by contrasts between BP at rest and BP during HUT. PC3 thus can be interpreted as 'BP reactivity' to HUT. Lower (i.e., larger negative) PC3 scores reflect increases in BP reactivity (i.e., tending toward orthostatic hypertension), whereas higher (i.e., larger positive) PC3 scores are associated with larger decreases in BP reactivity (i.e., tending toward orthostatic hypotension). Again, 'BP reactivity' (PC3) and individual measures of BP reactivity (e.g., DSBP 1 ) from our data correlated well; the correlations between PC3 and calculated measures of BP reactivity ranged from À0.547 to À0.685. As individual PC3 scores are not by themselves intuitively meaningful, we examined the distribution of PC3 scores for the range of BP reactivity. We found that 'normoreactors' had an average PC3 score of approximately 0. People with orthostatic hypotension had average PC3 scores of approximately 1.4, whereas individuals with orthostatic hypertension had a mean PC3 near À0.4. These mean PC3 scores illustrate that individuals who incur large increases in BP during HUT from rest have lower PC3 scores, whereas individuals who incur large decreases in BP during HUT from rest have higher PC3 scores.
Heritability estimates of principal component measurements Table 4 contains the heritability estimates, as well as parameter estimates for the trait means, trait variances and covariate effects for each principal component. Significant (Po0.05) heritabilities were detected for 'general BP' (h Knowing that the components are orthogonal at the phenotypic level, we used a bivariate extension of the univariate quantitative genetic procedure to determine whether or not the components were independent at the genetic level. Genetic correlations among the PC were no different from zero, indicating that the genetic effects among these components are not shared and independent.
Covariate effects accounted for 40.4, 16.4 and 10.7% of the total phenotypic variation in PC1, PC2 and PC3, respectively. There were significant age effects on all three components with the effect being curvilinear for 'general BP' (PC1) and 'pulse pressure' (PC2), and linear for 'BP reactivity' (PC3). The effect of sex was significant for 'general BP' (PC1), but not for 'pulse pressure' (PC2), or 'BP reactivity' (PC3). Males had higher 'general BP' (PC1). There were significant effects of BMI and hypertensive medication use on 'general BP' (PC1), with heavier individuals and those taking medication having higher values. Cigarette smoking had a significant effect on 'pulse pressure' (PC2). Recalling that higher 'pulse pressure' (PC2) and 'BP reactivity' (PC3) are reflected by larger negative scores, smokers thus had higher 'pulse pressures'. The only covariate with a significant effect on 'BP reactivity' (PC3) was age, with older individuals tending towards orthostatic hypotension (i.e., having higher PC3 scores).
Discussion
The results of this study indicate that heritable components exist for measures of BP at rest and during HUT. Our heritability estimates for the individual measures of BP are similar to those found in studies using nuclear or extended pedigree study designs. Heritabilities are population specific, however, and some caution is needed when comparing the results of different studies. Nevertheless, heritability estimates are relatively robust across studies, and differences in heritability estimates among study populations may reflect the differential influence of environmental factors as well as any genetic differences. When compared to other studies, our heritability estimates for supine and seated BP are within the range of those reported for resting BP, which range from 0.18 to 0.81. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] To date, heritability estimates of orthostatic BP from extended family data are limited, and most of them come from studies examining the orthostatic changes from sitting to standing. Our heritability estimates for BP during HUT fall in the middle of the range reported by others. Hunt et al. 42 found heritability estimates for standing BP that ranged from 0.08 to 0.16 for SBP and from 0.11 to 0.21 for Our results from the PCA indicate that multiple measurements of BP can be reduced to three interpretable components that represent (1) the overall effects of BP at rest and during HUT (i.e., 'general BP'), (2) 'pulse pressure' and (3) 'BP reactivity'. The three extracted components represent different aspects of BP during HUT such that each of these factors is distinct and uncorrelated with the others. The value of this procedure is that it enables us to examine 'BP reactivity' (PC3) independently from 'general BP'. This approach thus overcomes some of the problems caused by the multicollinearity of study data that are inherent in epidemiological studies focusing on traditional measures of BP and BP during challenge. For example, in a study by Rose et al., 8 adjusting for baseline BP attenuated the association between future incident hypertension and both positive and negative BP reactivity to postural challenge. It is possible that Rose et al.'s findings may be owing to an overadjustment for baseline BP. This type of adjustment may mask potential associations between BP reactivity and CVD risk because part of the variation in BP reactivity is removed.
The three PC identified may represent 'latent factors' underlying BP physiology in the challenge state and may represent specific physiological pathways that are involved in BP homeostasis. For example, let us assume that PC2 more accurately represents arterial stiffness, and PC3 characterizes physiological pathways or systems such as baroreceptors, b-adrenergic receptors or norepinephrine levels 3, 5 that are independent of arterial stiffness. As conventional measures of PP and BP reactivity are often correlated, we are usually unable to make a distinction between the two underlying and independent components. Consequently, arterial stiffness or compliance, which is usually measured by pulse pressure, is often cited as a physiological precursor or important predictor of BP reactivity. 3, 5 PCA may therefore provide some additional insight into the factors regulating BP. Our analyses have identified a component of BP that is independent from PP, but related to 'BP reactivity' (i.e., PC3) and may more accurately represent true BP reactivity. Furthermore, this component has a significant genetic basis.
An additional benefit from the PCA of BP reactivity data is that the number of variables examined is reduced and thus we can better clarify the effects of covariates on BP variation. In our study population, the covariate effects of smoking, hypertensive medication and body mass on individual measures of BP at rest, BP during HUT and BP reactivity were found to be inconsistent. The apparent lack of a discernible pattern makes it difficult to determine whether or not the influence of covariates does in fact differ among these different measures of BP. Our analyses show that BMI and hypertensive medication use influence only 'general BP' (PC1), whereas cigarette smoking only has an effect on 'pulse pressure' (PC2). Interestingly, the only significant covariate for 'BP reactivity' was age. These findings contradict some studies examining BP response to postural change. For example, some studies have found that DSBP to postural change (standing) is influenced by cigarette smoking, 3, 5 certain antihypertensive medication 8, 43 and BMI. 3, 5, 8 However, other studies indicate that BP response to postural change is not influenced by cigarette smoking, 8, 13, 43 hypertensive medication 3, 5 or BMI. 4, 13 It is possible that the covariate effects observed in some of these studies are influenced or obfuscated by multicollinearity among BP measures, and that the observed significant covariate effect may reflect an association with the portion of the variance of BP reactivity that is correlated with resting or general BP.
Our study has a number of strengths including the use of an extended family study design and the use of a tilt-table for orthostatic challenge testing. To our knowledge, our study is the first genetic study to quantify genetic and environmental effects on BP to a tilt-table challenge. Moreover, our study appears to be the first quantitative genetic analysis using PCA to examine the relationship among BP measures during postural challenge. There are, however, some limitations to our study. As our use of PCA partitions the maximum variance into the first component, one of the limitations to this study is that the variation in the third component is relatively small (6.4%). Nevertheless, despite the smaller phenotypic variance, the loadings were relatively easy to interpret and we were still able to estimate a significant heritability. Another limitation of our study is that our results were based on the analyses of white families and may not be generalizable to other populations or ethnic groups. Although the results for our population are interesting, replication of this study in other populations is clearly warranted.
In summary, our results indicate that most of the variation in BP reactivity data can be consolidated into three PC (i.e., 'general BP', 'pulse pressure' and 'BP reactivity'), and each of these orthogonal components is significantly influenced by additive genetic factors and different sets of non-genetic factors. As genetic marker data become available, future analyses, including quantitative trait linkage analysis, are planned in order to determine whether chromosomal regions are linked to traits such as 'BP reactivity'. Identification of potential quantitative trait loci specific to 'BP reactivity' may lead to a better understanding of the exact physiological pathway or system 'BP reactivity' represents. Identification of these potential pathways may, in turn, better elucidate any potential advantages of using BP reactivity measures over conventional resting BP for predicting future CVD.
